Latest filing published 10 Jul 2019 for Whitehawk Therapeutics, Inc., €3,618.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
All filings by Joseph H. Gardner on record concern Whitehawk Therapeutics, Inc. Over a trading history stretching from 15 March 2017 to 10 July 2019, the count stands at 3 filings.
Every open-market trade on record is a purchase: 3 purchases worth €479k, and no sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2019, the count stands at 2 purchases and no sales.
In size, the median ticket on the buying side is €3,973.
The newest entry dates from 10 July 2019: an open-market purchase of €3,618, in Whitehawk Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations